Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Laboratories: Dividend Stock Analysis
Seeking Alpha
Friday, February 11, 2011 - 12:00pm
tags:
Abbott Laboratories, dividends
Merck Plans $8.1 Billion-$8.5 Billion R&D, Daily Says
Bloomberg
Friday, February 11, 2011 - 11:59am
tags:
R&D, Merck
Gilead refiles for approval of HIV drug
Bizjournals.com
Friday, February 11, 2011 - 7:46am
tags:
HIV, Gilead Sciences, Truvada
Targacept posts $2.2M loss
Bizjournals.com
Friday, February 11, 2011 - 7:45am
tags:
earnings, Targacept
The Next Big Pharma Share?
Motley Fool
Friday, February 11, 2011 - 7:44am
tags:
GSK, Shire, AstraZeneca
The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
Forbes
Friday, February 11, 2011 - 7:43am
tags:
diabetes, insulin, Merck, GSK, Novo Nordisk, Eli Lilly
Nymox: Another Look at Enlarged-Prostate Drug
TheStreet.com
Thursday, February 10, 2011 - 10:52am
tags:
Nymox, enlarged prostate, NX-1207
Acquisition Talks of Amarin Continue to Progress
Seeking Alpha
Thursday, February 10, 2011 - 10:51am
tags:
M&A, Amarin
Healthcare Reform and Generic Drugs will Drive Branded Prescription Drug Prices Higher
Pharmareform
Thursday, February 10, 2011 - 10:49am
tags:
drug pricing, generics, healthcare reform
Crucell’s Quinvaxem Problems Have Been Resolved, WHO Says
Bloomberg
Thursday, February 10, 2011 - 10:48am
tags:
Crucell, Quinvaxem, WHO, vaccines
Datamonitor: Diabetes growth won't stop CV, metabolic market slide
Fierce Pharma
Thursday, February 10, 2011 - 10:37am
tags:
diabetes, cardiovascular disease, generics, biosimilars
FDA OKs generic version of Duragesic pain patch
Yahoo/AP
Thursday, February 10, 2011 - 10:29am
tags:
Duragesic, pain patches, generics, FDA, Covidien, JNJ
Botox 'little help' for migraines
BBC News
Thursday, February 10, 2011 - 10:28am
tags:
Botox, migraines, Allergan
Hard Luck: Why Viagra Is About to Lose Its No.1 Status to Cialis
BNET Pharma
Thursday, February 10, 2011 - 10:09am
tags:
Viagra, erectile dysfunction, Pfizer, Eli Lilly, Cialis
Alexion Pharma 4Q profit drops without tax benefit
Yahoo/AP
Thursday, February 10, 2011 - 10:06am
tags:
Alexion, earnings
Once a Decade Isn't Enough, Elan
Motley Fool
Thursday, February 10, 2011 - 10:03am
tags:
Elan, earnings
Cephalon signs Alba Therapeutics option agreement
Yahoo/AP
Thursday, February 10, 2011 - 10:02am
tags:
Cephalon, Alba Therapeutics, celiac disease
Idenix Falls as FDA Places Hold on HIV Drug, Releases Another
Bloomberg
Thursday, February 10, 2011 - 10:00am
tags:
Idenix, FDA, HIV, GSK, ViiV Healthcare
Sanofi CEO Says Genzyme Offer Could Be Extended, La Tribune Says
Bloomberg
Thursday, February 10, 2011 - 9:58am
tags:
M&A, Sanofi, Genzyme
Merck’s Fosamax Didn’t Cause Jaw Disease, Jury Is Told
Bloomberg
Thursday, February 10, 2011 - 9:14am
tags:
Merck, Fosamax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.